Lead sponsor
Epix Pharmaceuticals, Inc.
3 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
3
Trials led
0
Ongoing
736
Total enrollment
55
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
3
Trials by status
Completed
1
Terminated
2
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of DonepezilAlzheimer's diseasePh 2Terminated420
Study of PRX-03140 Monotherapy in Subjects With Alzheimer's DiseaseAlzheimer's diseasePh 2Terminated236
Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With AriceptAlzheimer's diseasePh 2Completed80